This is a major fund raise by FlowGroup (FLOW). It has most of it in the bag and will raise up to £29 million. This is institutional territory but it is - very decently - letting in Private Punters via PrimaryBid with an offer announced at 5.12 PM today and which closes at 9 PM tonight.  The up to £4 million being raised is being done at 1p - the shares closed at 1.1p-1.15p. But this is not a party for spivs and flippers this is a proper City fundraise which FOR ONCE you can take part in - but hurry, the deadline is 9PM TONIGHT SIGN UP NOW HERE

The world's best known resource group Sprott has published its monthly report and warns again that those with no gold exposure will lose out big time. Analyst Troy Reik writes:

Arron Banks is a big UKIP backer as is his pal Jim Mellon, although the old asset stripper of Uramin infamy is not actually allowed to vote in the UK as he lives offshore in the Isle of Man. Private Eye this week looks at how the two men have not exactly prospered by backing the underperforming, sub scale, IOM-based, AIM-listed, bank Manx Financial (MFX). It also questions whether Banks is as rich as he claims. Enjoy...

Strat Aero (AERO) the AIM casino listed company that under a former management team repeatedly lied to investors is still a joke. In January and February of this year it raised $1.23 million gross (call it $1.1 million net) promising that 2017 would be a turnaround year. One would hope so - in 2016 it lost c$3.5million. So how is it going? Not well I suggest, judging by a joke RNS today.

I reckon that shares in gold miner Altyn (ALTN) are cheap as you can see HERE. Last week the company did a two day City roadshow (not raising cash) in which it gave a full presentation to fund managers. But why should the City boys & girls playing with other folks cash be the only ones to see the presentation? In that spirit...

Katoro Gold (KAT) was once the joke stock Opera Investments which did appear "accident prone". But it has now had the gold assets of Kibo (KIBO) injected into it, done a fund raise, moved to the AIM Casino and is, apparently, a whole new beast. House broker Beaufort has published a detailed note explaining why the shares should soar from 5.25p to 11.7p. I should note that Kibo retains a 56% stake in Katoro and we own a few Kibo shares.

AIM-listed Advanced Oncotherapy (AVO) has this morning announced another conversion of death-spiral loan notes by Bracknor. That is not news – there have been plenty already and there are many more to come. But for the third time in succession we seem to have different terms being applied. Surely it is time for the company to tell the market what is going on?

My last piece rather naively thought that Echo Energy’s (ECHO) new institutional equity investor, Spartan Fund, or Pegasus Fund as it became, would want to put its funds in at a fair valuation and thought the share price would go down. I was wrong and must assume that it is all part of the connected group of institutions and individuals here that have led to an insane valuation that appears to indicate that the mere mention of James Parsons is worth £100 million. That is nonsense and this is a massive sell.

There are plenty of companies on AIM where it is hard to see where the value is and why private investors are so keen to chuck their savings into the shares, and BOS GLOBAL Holdings (BOS) would certainly seem to fit the bill!

Hello Share Crunchers. I hold stock in an awful lot of oil producers, perhaps too many. But one company which has never lit my fire is Cairn Energy (CNE). Maybe I should dip in, though.

Aeorema Communications (AEO) has followed a 12:43pm profit warning ah sorry, “Trading Update” announcement, in December with a 1:01pm “Trading Update” announcement today. I’ll give you whatever odds you want on this being good news…

Take a look! European investors are clearly failing to grasp the very significant financial and commercial benefits available for Orphan or Rare Disease drug developers. So much so in fact, that sector-focussed Amryt Pharma (AMYT) finds no quoted peers in London, yet a good basket of NASDAQ-listed comparables are seen to command a significant premium despite mostly being pre-revenue and somewhat earlier in their development. Such anomalies can and, of course, do rapidly correct. 

Any reader of my pieces will know I hold Challenger Acquisitions (CHAL) in pretty low regard but the outrageous ramping that has now gone on for the last four trading days is an absolute disgrace and the FCA should take a look. I’ll explain.

Doesn’t time fly when you’re having fun? It’s now been a year since Boxhill Technologies’ (BOX) CEO stepped down and Lord Razzall stepped into the role of Executive Chairman while looking for a replacement. Worth having a look how the boss has done – not good is the short answer, so doubt shareholders have been having too much fun. Read on for the longer answer.

The sold-out success that was the 1st April 2017 UK Investor Show again saw five 'Dragon's Den' sessions where a number of CEOs each gave a pitch and three Dragons each picked one stock for a £1,000 investment. How are they faring so far?...

With some great investigative journalism of which this website would have been proud, Brokerman Dan flushed it out a few weeks ago. The former bank robber - correctly - stated that Andalas (ADL) was looking to raise £1 million at 0.06p and the AIM listed crock of shit suspended its shares. Today they are unsuspended after the company raised £600,000 at 0.1p. It says this is at a premium to the suspension price. But it is a spoof, Andalas is still bust. It is insolvent as of today!

I can’t help but notice that in the wake of a couple of Bracknor death-spiral loan note conversions, shares in AIM-listed Advanced Oncotherapy have rather slipped again. Indeed, having scraped onto the 27.5p watermark on Monday last week (and thus avoided an EGM to drop the nominal price of the shares) as the result of spoof boardroom buying, it has been one-way traffic ever since, down to 22.75p last seen.

Yesterday lunchtime (1pm – the new no-one-is-watching o’clock) ShareProphets AIM-China Filthy Forty purveyor of all things fishy, Aquatics Foods Group (AFG) served up a Q1 trading statement showing broadly flat sales, but rising costs. The really good news is that the cash-pile is even higher than before, at RMB 485 million – c. £54 million, or about five times the market capitalisation. The bad news….

One of the most fascinating scenes I’ve seen for some time is the sight of Big Donald jigging around with some sort of weird entertainment put on by the Saudi’s for the President's visit. It almost made me forget the big benefit of this amiable state visit on share shifters like us. And that of course is that the President’s friendly reception sent the oil price up.

AIM-listed travel agent and wannabe Greek holiday resort developer Minoan (MIN) announced a small bolt-on acquisition this morning….and a placing. Oh, and an update on its debt facility due to expire at the end of June. It is disappointing to see a placing (at 9p), but in the general scheme of things it is a relatively small amount so the pill is sugared to some extent.